Kos Announces Presentation at the Lehman Brothers Ninth Annual Global Healthcare Conference
01 3월 2006 - 10:36PM
Business Wire
Kos Pharmaceuticals, Inc. (Nasdaq:KOSP) today announced that Adrian
Adams, President and Chief Executive Officer, will present at the
Lehman Brothers Ninth Annual Global Healthcare Conference, which is
being held March 8 - March 10, 2006 in Miami, Florida. Kos'
presentation will take place at 3:45 pm ET on Wednesday, March 8,
2006. Interested parties can access the webcast information by
going to the investor relations section of Kos' website at
www.kospharm.com, and referencing upcoming events. About Kos Kos
Pharmaceuticals, Inc. is a fully integrated specialty
pharmaceutical company engaged in developing, commercializing,
manufacturing and marketing proprietary prescription products for
the treatment of chronic diseases with a particular focus on the
cardiovascular, metabolic and respiratory disease areas. The
Company's principal product development strategy is to reformulate
existing pharmaceutical products with large market potential to
improve safety, efficacy, and patient compliance. Kos' strategy
also includes making measured investments in new chemical entity
research through in-house and sponsored research, scientific
in-licensing and general corporate development activities. The
Company currently markets Niaspan(R) and Advicor(R) for the
treatment of cholesterol disorders, Azmacort(R) for the treatment
of asthma, Cardizem(R)LA for the treatment of hypertension and
angina, and Teveten(R) and Teveten(R)HCT for the treatment of
hypertension. Kos has a strong and growing research and development
pipeline including proprietary drug delivery technologies in
solid-dose, inhalation and aerosol metered-dose device
administration to help fuel sustained, organic sales growth into
the future.
Kos (NASDAQ:KOSP)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Kos (NASDAQ:KOSP)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024